[ad_1] Three months after the second dose (administered 28 days after the first), participants in Moderna’s covid-19 vaccine study demonstrated high levels of antibodies. “This suggests that the vaccine will provide lasting immunity,” the lead researcher said. A new study recently published in The New England Journal of Medicine suggests …
Read More »